miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL. Int J Nanomedicine. 2018;13:2295–2307. The authors have advised Figure 2B on page 2301 is incorrect. Due to an error at the time of figure assembly B1 and B2 were duplicated. The correct Figure 2 is shown bel...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/285b634ed73b48069d0fb1ac8ea69293 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL. Int J Nanomedicine. 2018;13:2295–2307.
The authors have advised Figure 2B on page 2301 is incorrect. Due to an error at the time of figure assembly B1 and B2 were duplicated. The correct Figure 2 is shown below.
The authors apologize for this error and advise it does not affect the results of the paper.
Read the original article |
|---|